Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II randomized double-blind trial of vaginal quadruple live Lactobacillus capsules for bacterial vaginosis
ChiCTR2200058973Phase 2Not yet recruiting
- Sponsor
- Beijing Tsinghua Changgung Hospital
- Start
- Feb 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of metronidazole in bacterial vaginosis (BV) (4 arms), sponsored by Beijing Tsinghua Changgung Hospital. Primary endpoint: vaginal microecology. Planned start Feb 2022; status: not yet recruiting.
02
Drugs
metronidazole
03
Conditions
bacterial vaginosis (BV)
Beyond the preview
Go deeper on ChiCTR2200058973.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200058973.